|
|
Volumn 344, Issue 1-2, 2014, Pages 229-231
|
|
Lambrolizumab induced central nervous system (CNS) toxicity
a
|
|
Author keywords
Cancer neurology; Drug toxicity; Immunotherapy; Lambrolizumab; Neuro oncology
|
|
Indexed keywords
DACARBAZINE;
ETIRACETAM;
IPILIMUMAB;
OXCARBAZEPINE;
PEMBROLIZUMAB;
PHENOBARBITAL;
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
AGED;
ATAXIA;
CANCER GROWTH;
CANCER STAGING;
CASE REPORT;
CEREBROSPINAL FLUID;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
FOLLOW UP;
GENE MUTATION;
HUMAN;
LETTER;
LIVER METASTASIS;
LUNG NODULE;
MALE;
METASTATIC MELANOMA;
MULTIPLE CYCLE TREATMENT;
NEUROTOXICITY;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
SEIZURE;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
VERTIGO;
CENTRAL NERVOUS SYSTEM DISEASES;
CHEMICALLY INDUCED;
ELECTROENCEPHALOGRAPHY;
MELANOMA;
NUCLEAR MAGNETIC RESONANCE IMAGING;
AGED;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC AGENTS;
CENTRAL NERVOUS SYSTEM DISEASES;
ELECTROENCEPHALOGRAPHY;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MALE;
MELANOMA;
|
|
EID: 84906794549
PISSN: 0022510X
EISSN: 18785883
Source Type: Journal
DOI: 10.1016/j.jns.2014.06.023 Document Type: Letter |
|
Times cited : (56)
|
|
References (4)
|
